Cyclophosphamide Anhydrous

CHEMBL88 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
261.1 g/mol
LogP
0.6
Phase
4

An anhydrous form of cyclophosphamide, a chemotherapy drug used to treat various cancers and autoimmune diseases. It works by interfering with DNA in rapidly dividing cells to stop their growth.

Molecular Weight

261.0800 g/mol

LogP

0.60

TPSA

41.60 Ų

Lipinski RO5

Pass

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=P1(N(CCCl)CCCl)NCCCO1

InChI

InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)

Molecular Formula

C7H15Cl2N2O2P

HBD / HBA

1 / 4

Rotatable Bonds

5

Heavy Atoms

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

An anhydrous form of cyclophosphamide, a chemotherapy drug used to treat various cancers and autoimmune diseases. It works by interfering with DNA in rapidly dividing cells to stop their growth.

Yes, Cyclophosphamide Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL88. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2907. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.